AI agent security on Kubernetes needs healthcare-specific enforcement

At a glance

What this is: This is an analysis of how healthcare platform teams should secure AI agents on Kubernetes, with the key finding that clinical workflows change the enforcement model.

Why it matters: It matters because IAM, NHI, and workload governance teams must treat AI agents that read and write clinical data as high-impact identities with runtime controls, not just as containers.

By the numbers:

• At 1 to 2.5% CPU overhead, kernel-level eBPF observation can stay within the budget many platform teams already accept for observability.

👉 Read ARMO's analysis of how healthcare platform teams should secure AI agents on Kubernetes

Context

Healthcare AI agent security is different because the protected object is not only data, but also clinical continuity. When an agent can read chart context, write into the EHR, and influence care decisions, runtime control decisions affect both security and patient safety. That is why healthcare Kubernetes environments need enforcement logic that understands workflow criticality, not just pod state.

The identity angle is genuine here because these agents behave like high-risk non-human identities with scoped permissions, tool access, and external data dependencies. The hard problem is not whether to observe and restrict them, but how to do so without breaking clinical operations, break-glass access, or evidence production for HIPAA and related assurance processes.

Key questions

Q: How should healthcare teams govern AI agents that access clinical systems?

A: Treat AI agents as managed identities with named ownership, scoped permissions, audit trails, and revocation. In healthcare, the governance bar should be higher than for ordinary automation because agents can touch regulated workflows, patient data, and legacy systems. Combine least privilege with human oversight for actions that could affect care delivery or privacy.

Q: Why do AI agents in healthcare change containment decisions?

A: Because killing or quarantining an agent can interrupt charting, ordering, or patient access at the exact moment clinicians depend on it. Security teams must weigh patient-safety impact against exfiltration risk and predefine response modes that preserve care continuity while still blocking suspicious external behaviour.

Q: What breaks when teams use generic zero-trust controls for clinical AI agents?

A: Generic zero-trust patterns often assume containment can happen without operational consequences. In healthcare, that assumption fails when the agent is mid-encounter or driving a clinical workflow, so teams need tiered enforcement and break-glass-aware response logic instead of a one-size-fits-all kill strategy.

Q: Who is accountable when an AI agent causes a clinical access problem?

A: Accountability remains with the organization and the humans who approved, owned, and monitored the agent. The agent is a governed actor, not a responsible party. Healthcare teams should make ownership visible, keep audit trails clear, and define escalation paths before the agent is put into production. That is the only way to preserve clinical accountability.

Technical breakdown

Runtime AI-BOM for clinical agents

A runtime AI-BOM is the observed list of endpoints, resources, and tools an AI agent actually uses in production. In healthcare, that matters because the declared deployment manifest often underestimates what the agent really touches, especially when retrieval plugins, FHIR endpoints, and external medical references are involved. For NHI governance, the runtime AI-BOM becomes the control surface for business associate scope, minimum-necessary review, and egress monitoring. It turns non-deterministic behaviour into an auditable inventory of access paths.

Practical implication: build enforcement and BAA scope around observed runtime behaviour, not declared architecture alone.

Declared versus observed permissions in Kubernetes

AI agents frequently request broad permissions at design time, then exercise only a fraction of them at runtime. The gap between declared and observed access is a governance signal, not just an optimisation opportunity. In Kubernetes, that gap is especially important for clinical agents because permissions may cover PHI reads, FHIR writes, and external retrieval sources that are not equally critical. The control challenge is to convert observation into a minimum-necessary attestation that can stand up in regulated environments.

Practical implication: review the declared-versus-observed permission gap per agent and reduce standing access to the minimum needed.

Containment when the agent is part of the workflow

Traditional containment assumes that stopping a compromised workload is always the right answer. In healthcare, that assumption fails for ambient scribes and other live agents whose output supports ongoing care. Soft quarantine, pause, stop, and kill all have different clinical consequences because the agent may be mid-encounter, mid-order, or mid-review. The correct choice depends on whether the agent is read-only, write-path enabled, or directly tied to patient access and documentation. That makes enforcement a clinical governance decision as much as a security one.

Practical implication: predefine containment modes by clinical criticality so the SOC does not improvise during an active encounter.

NHI Mgmt Group analysis

Clinical AI security is now an identity governance problem, not only a Kubernetes problem. Once an agent can read charts, write notes, or influence treatment paths, it behaves like a non-human identity with patient-safety consequences. That changes the governance burden from pod protection to lifecycle control, access scope, and behavioural attestation. Practitioners should treat clinical agents as regulated identities with runtime accountability.

The named failure mode is the clinical blast radius gap. Healthcare teams often assume containment can happen cleanly after detection, but live agents can create a patient-safety event the moment they are interrupted. This is why enforcement has to be designed around clinical criticality, not a generic kill-switch model. The practical conclusion is that containment policy must be tiered before production rollout.

Observe-to-enforce only works when the observation window is clinically tolerable. For ambient scribes, prior-auth automations, and decision-support agents, a production learning period can itself expose PHI or distort care. That means some agents need staging validation with production parity rather than live observation in the clinical path. Teams should align rollout method to workflow risk, not platform convenience.

Runtime evidence is becoming the new minimum-necessary record. The article’s emphasis on observed endpoints, FHIR paths, and external calls reflects a broader shift in identity governance: declared permissions are no longer enough when agent behaviour is dynamic. This is where AI-BOM style visibility intersects with NHI lifecycle governance. Practitioners should use observed behaviour as the basis for access review, attestation, and offboarding decisions.

Clinical availability and security are converging on the same control plane. In healthcare, a containment action can interrupt documentation, ordering, or prior authorisation, so security teams must coordinate with clinical owners before an incident happens. That does not weaken control, it makes control defensible. Practitioners should build response modes that preserve safety while still preventing exfiltration and scope drift.

What this signals

AI-BOM visibility will become a practical requirement for regulated AI operations. Healthcare teams will not be able to defend runtime access, evidence production, or clinical containment with architecture diagrams alone. Observed endpoints, write paths, and external retrieval sources will need to be tracked as part of the identity record, especially where agents handle PHI or influence orders.

The next governance pressure point is not model quality, but response fidelity. As more clinical workflows depend on AI agents, security teams will need containment modes that are aligned to clinical criticality and audited like any other privileged access path. That shift puts workload identity, access review, and incident response into the same control conversation.

Runtime behaviour will increasingly define the access boundary. That is the strongest lesson from this article for identity programmes. When declared permissions and observed behaviour diverge, the governance baseline has to follow the latter, not the former, and that is true for both NHI and human-assisted clinical workflows.

For practitioners

• Define clinical criticality tiers for every AI agent Classify ambient scribes, CDS agents, and prior authorisation automations separately, then map each tier to an approved containment mode such as pause, soft quarantine, stop, or kill. Make the tiering decision part of go-live governance, not incident response improvisation.
• Inventory the runtime AI-BOM for each agent Capture the actual FHIR resources, external references, egress endpoints, and write paths each agent uses in production. Reconcile that runtime AI-BOM against the deployment manifest and BAA scope to identify hidden access paths before they become exposure paths.
• Use observed behaviour for minimum-necessary attestation Compare declared permissions to observed tool use, resource access, and output patterns so access review reflects what the agent actually does. For write-path agents, include output drift and recommendation distribution in the attestation evidence.
• Pre-stage break-glass-compatible enforcement Document fail-open paths for authorised emergency workflows so legitimate clinical overrides are not blocked by behavioural baselines. Test those paths in a controlled environment and keep them separate from normal enforcement defaults.

Key takeaways

• Healthcare AI agents on Kubernetes create a clinical blast radius that includes PHI exposure, recommendation integrity, and workflow continuity.
• Observed runtime behaviour is the governance baseline that matters most when agents write into clinical systems and external endpoints drift.
• Security teams should tier containment by clinical criticality so enforcement protects patients without breaking essential care workflows.

Key terms

• Runtime-Derived AI-BOM: An inventory of the models, tools, adapters, and components that actually loaded and ran in an AI workload. Unlike a declared bill of materials, it reflects live system state, which is essential when components appear only at runtime or are pulled dynamically from external sources.
• Blast Radius: The potential scope of damage if a specific credential or identity is compromised. Identities with broad permissions have a larger blast radius and represent a higher priority for least-privilege enforcement and security controls.
• Break-glass-compatible enforcement: Break-glass-compatible enforcement is a control design that allows approved emergency access or workflow exceptions without treating every deviation as malicious. In regulated healthcare environments, it preserves emergency care while still limiting exfiltration and documenting the exception for later review.
• Minimum-Necessary Attestation: Minimum-necessary attestation is evidence that shows an identity used only the amount of data and access required for the task. In agentic healthcare workflows, the proof comes from what the agent retrieved and wrote under load, not from a declared policy alone.

What's in the full article

ARMO's full blog covers the operational detail this post intentionally leaves for the source:

• Deployment-level AI-BOM and eBPF enforcement patterns for Kubernetes
• Per-agent containment defaults for ambient scribes, CDS, and prior auth workflows
• Runtime evidence mapping for HIPAA audit controls and minimum-necessary attestation
• Operational examples of break-glass-compatible enforcement paths

👉 ARMO's full post covers the runtime controls, clinical enforcement defaults, and evidence outputs in more detail.

Deepen your knowledge

NHI Foundation Level course, the industry's only accredited NHI security programme, covers NHI governance, machine identity security, and secrets management. It is built for practitioners who need a practical framework for controlling runtime access and lifecycle risk.